Prevalence and risk factors of osteoporosis and osteoarthritis among Beta Thalassemia patients

Main Article Content

Sevil Sadri
Vildan Gürsoy
Selime Ermurat
Elif Güler Kazancı


Objective: This study aims to examine the clinical and radiological features of skeletal changes in patients with thalassemia and provide a comprehensive overview of osteoporosis and osteoarthritis in these patients.

Materials and Methods: We conducted a retrospective analysis of patients with transfusion-dependent thalassemia, both adults and children, who received follow-up care at our thalassemia center between 2019 and 2020.. Thalassemia was diagnosed via hemoglobin electrophoresis. Transfusion-dependent patients were defined as those who received transfusions every 2-4 weeks, while the control group consisted of individuals with thalassemia trait/carriers.. Both groups were analyzed for clinical characteristics, and Dual-energy X-ray absorptiometry (DEXA) scans, and radiographic images of the knee and wrist were evaluated.

Results: DEXA scans of the femur and lumbar spine showed that the prevalence of osteoporosis , Synovial hypertrophy of the wrist joint , wrist effusion , knee effusion, and Power Doppler signals on wrist ultrasound scans was statistically significantly higher in transfusion-dependent thalassemia compared to patients with thalassemia carriers.

Conclusion: Beta thalassemia is an inherited multisystem disease that leads to various musculoskeletal abnormalities. Knowledge of the musculoskeletal manifestations of thalassemia allows clinicians to guide their treatment. Familiarity with the radiological features of beta thalassemia is crucial for physicians in the timely diagnosis and management of thalassemia and its complications


Download data is not yet available.

Article Details

How to Cite
Sadri, S., Gürsoy, V. ., Ermurat, S., & Kazancı, E. G. . (2023). Prevalence and risk factors of osteoporosis and osteoarthritis among Beta Thalassemia patients . Medical Science and Discovery, 10(3), 195–200.
Research Article
Received 2023-02-25
Accepted 2023-03-19
Published 2023-03-20


Galanello R, Origa R. Beta-thalassemia. Orphanet J Rare Dis. 2010;5:11.

Bain B. Haemoglobinopathy Diagnosis. Oxford, UK: Blackwell Publishing; 2006.

Aksoy M, Camlı N, Dinçol K, Erdem S, Dinçol G. On the problem of “rib-within-a- rib” appearance in thalassemia intermedia. Radiol Clin Biol 1973;42:126-133.

Cooley TB, Witwer E, Lee P. Anemia in children with splenomegaly and peculiar changes in the bones:report of case.Am J Dis Child 1927;34:347-63.

Altinoz MA, Gedikoglu G, Deniz G. β-Thalassemia trait association with autoimmune diseases: β-globin locus proximity to the immunity genes or role of hemorphins?

Immunopharmacol Immunotoxicol 2012;34:181-90

P.Mahachoklertwattana, V.Sirikuluchayanonata, A. Chuansumrit et al., Bone histomorphometry in children and adolescents with beta-thalassemia disease: iron associated focal osteomalacia, Journal of clinical endocrinology and metabolism, vol.88,no. 8, pp.3966-3972,2003.

P.Pennisi, G. Pizzarelli, M. Spina, S. Riccobene, and C.E.Fiore, Quantitative ultrasound of bone and clodronate effects in thalassemia-induced osteoprosis, Journal of Bone and Mineral Metabolism, vol.21, no.6, pp 402-408,2003

K. H. Ehlers, P. J. Giardina, M. L. Lesser, M. A. Engle, and M. W. Hilgartner, "Prolonged survival in patients with beta-thalassemia major treated with deferoxamine,” The Journal of Pediatrics, vol. 118, no. 4, pp. 540–545, 1991.

M. Karimi, A. F. Ghiam, A. Hashemi, S. Alinejad, M. Soweid, and S. Kashef, "Bone mineral density in beta-thalassemia major and intermedia,” Indian Pediatrics, vol. 44, no. 1, pp. 29–32, 2007.

C. E. Jensen, S. M. Tuck, I. E. Agnew et al., "High incidence of osteoporosis in thalassaemia major,” Journal of Pediatric Endocrinology and Metabolism, vol. 11, no. 3, pp. 975–977, 1998.

Osteoporoz ve diğer metabolik kemik hastalıkları çalışma grubu. Osteoporoz ve metabolik kemik hastalıkları tanı ve tedavi kılavuzu, 2022. (Working group for osteoporosis and other metabolic bone diseases. Guidelines for diagnosis and treatment of osteoporosis and metabolic bone diseases), 2022.

S.Yilmaz Demiriz, S.Sarikaya. Diz Osteoartriti Hastalarında Tanı ve Kılavuzlar Işığında Güncel Tedavi (Diagnosis and Current Treatment Modalities in Knee Osteoarthritis in the Light of Guidelines). Med J West Black Sea 2021;5(2): 115-124

Vogiatzi MG, Maclin AE, Fung EB, Cheung AM, Vichinsky E, et al. (2009): Bone disease in thalassemia: a frequent and still unsolved problem. J Bone Miner Res.; 24 (3):543-547.

Chatterjee R and Bajoria R. (2009): Osteopenia, osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment. Hemoglobin; 33 (1): S136-138.

Dede AD, Trovas G, Chronopoulos E, Triantafyllopoulous IK et al. Thalassemia - associated of osteoprosis: a systematic review on treatment and breif of overreview of the disease. Osteoporos int. 2016;27(12):3409-25.doi:10.1007/s00198-016-3719

Chatterjee R and Bajoria R. (2009): Osteopenia, osteoporosis syndrome in patients with thalassemia: understanding of type of bone disease and response to treatment. Hemoglobin; 33 (1): S136-138.

Johnell O, Kanis JA, Oden A, Johansson H, De Laet C, et al. (2005) Predictive value of BMD for hip and other fractures. J Bone Miner Res 20: 1185-1194.

Angastiniotis M, Pavlides N, Aristidou K, Kanakas A, Yerakaris M, et al. (1998) Bone pain in thalassaemia: assessment of DEXA and MRI findings. J Pediatr Endocrinol Metab 11: 779-784.

Perrotta S, Cappellini MD, Bertoldo F, et al. Osteoporosis in beta-thalassaemia major patients: analysis of the genetic background. Br J Haematol. 2000;111:461–466.

Chatterjee R, Bajoria R. Osteopenia-osteoprosis syndrome in patients with thalassemia:understanding of type of bone disease and response to treatment. Hemoglobin.2009;33 Suppl 1:S:136-8 Doi:10.3109/03630260903347898

Baytan B, Saglam H, Sahin E et al. Evaluation of endocrine complications in patients with thalassemia major. Current Pediatrics.2008;6:58-65

Mahachoklertwattana P, Chuansumrit A, Sirisriro R et al. Bonem mineral density, Biochemical and hormonal profiles in suboptimally treated children and adolescents with beta-thalassemia disease. Clin Endocrinol (Oxf).2003;58(3):273-9.doi:10.1046/j.1365-2265.2003.01707.x.

Merchant R, Udani A, Puri V, et al. Evaluation of osteopathy in thalassemia by bone mineral densitometry and biochemical indices. Indian J Pediatr. 2010;77:987–991.

Shamshirsaz AA, Bekheirnia MR, Kamgar M, et al. Metabolic and endocrinologic complications in beta-thalassemia major: a multicenter study in Tehran. BMC Endocr Disord. 2003;3:4.

Toumba M, Skordis N. Osteoporosis syndrome in thalassamia major:an overview. J osteoporos. 2010;2010:53673.doi:10.4061/2010/537673.

El-Nashar M, Mortagy AK, El-Beblawy NM, et al. Para-thyroid hormone in pediatric patients with β-thalassemia major and its relation to bone mineral density; a case control study. Egypt J Med Hum Genet. 2017;18:75–78.

Pirinççioğlu AG, Gökalp D, Söker M. Parathyroid functions in thalassemia major patients. Ann Clin Endocrinol Metabo. 2017;1: 015–019.

Fung EB, Auguilar C, Micaily I et al. Treatment of vitamin D deficiency in transfusion -dependent thalassemia. Am J Hematol. 2011;86(10):871-3.Doi:10.1002/ajh.22117

Onur O, Sivri A, Gümrük F, Altay C. Beta thalassemia: a report 20 children. Clin Rheumatol. 1999;18(1):42-4. Doi:10.1007/s100670050050

Cohen AR, Galanello R, Piga A, De Sanctics V et al.aftey and efectivness of long-term therapy with the oral iron chelator defereprone.llod 2003;102(5):1583-7.doi:10.1182/blood-2002-10-3280

Bakan B, Eser Ö, İnci MF.valuation of risk factors for scoliosis in children with thalaassemia major.

Currarino G, Erlandson ME. Premature fusion of the epiphyses in Cooley's anemia. Radiology. 1964;83:656–64.

Lawson JP (2018) Thalassemia imaging. Blood article (serial on- line). Available from 396792-overview. Accessed 10/29/2020

Hassanzadeh M. Images in clinical medicine. Extramedullary hematopoiesis in thalassemia. N Engl J Med. 2013;369(13):1252.

Kellenberger CJ, Sehmugge M, Saurenmann T et al (2004): Radiographic and MRI features of deferiprone-related arthropathy of the knees in patients with -thalassemta. AIR Am J Roeatgenol., 183: 989-994.

Drakonaki E E, Goumenakis M, Maragaki S,et al (2010): Musculoskeletal ultrasonography in beta-thalassemia major. Poster presentation in European Society of Radiology (ECR); C-2241

Noureldine MHA, Taher AT, Haydar AA, Berjawi A, Khamashta MA, Uthman I. Rheumatological complications of beta-thalassae- mia: an overview. Rheumatology (Oxford). 2018;57(1):19–27.